V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough

Progyny Executive Compensation (FY25)

PGNY · Executive and director compensation, fiscal 2022 to 2025

The Progyny brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Data as of September 7, 2026Latest filing (8-K): May 27, 2026
9 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Progyny brief$1,500Get the executive brief
256 figures on this page: 251 cited to the filing that reported them, 5 calculated from figures it prints. See the citations
Chief executive, fiscal 2025
◇
Peter Anevski
Latest say-on-pay support
=
May 21, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Peter Anevski: $1,361,112 → $7,220,612
CEO pay ratio: 12:1 → 46:1 (283.3% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Progyny's chief executive and what were they paid?
Peter Anevski was paid $7,220,612 in total compensation as Chief Executive Officer for fiscal 2025. Compared with the $1,361,112 reported for fiscal 2024, Anevski's total was up.
What was Progyny's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 94.1% of votes cast including abstentions in favor at the meeting held May 21, 2026.
Which companies are in Progyny's peer group?
The disclosed peer group names Alignment Healthcare, Inc., Astrana Health, Inc., Azenta, Inc., Certara, Inc. and CorVel Corporation, among others.
What is Progyny's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 46:1, against median employee compensation of $156,677.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Peter Anevski
Chief Executive Officer
◇—◇◇◇—◇◇
David Schlanger
Executive Chairman
◇—◇◇◇—◇◇
Michael Sturmer
President
◇—◇◇◇—◇◇
Mark Livingston
Chief Financial Officer
◇——◇◇—◇◇
Allison Swartz
EVP, General Counsel and Secretary
◇◇◇◇——◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Sturmer
President
◇—◇◇◇—◇◇
Mark Livingston
Chief Financial Officer
◇—◇◇◇—◇◇
Peter Anevski
Chief Executive Officer
◇———◇—◇◇
Allison Swartz
EVP, General Counsel and Secretary
◇———◇—◇◇
David Schlanger
Executive Chairman
◇———◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Sturmer
President
◇—◇◇◇—◇◇
Mark Livingston
Chief Financial Officer
◇—◇◇◇—◇◇
Allison Swartz
EVP, General Counsel and Secretary
◇—◇◇◇—◇◇
Peter Anevski
Chief Executive Officer
◇———◇—◇◇
David Schlanger
Executive Chairman
◇———◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Peter Anevski
Chief Executive Officer
◇—◇◇◇—◇◇
Melissa Cummings
Chief Operating Officer
◇—◇◇◇—◇◇
Mark Livingston
Chief Financial Officer
◇—◇◇◇—◇◇
Geoffrey Clapp
Chief Product Officer
◇—◇◇◇—◇◇
Allison Swartz
Executive Vice President, General Counsel and Secretary
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Allison SwartzRSU———◇——◇
Allison SwartzOPTION———◇—◇◇
Allison SwartzRSU———◇——◇
Geoffrey ClappRSU———◇——◇
Geoffrey ClappOPTION———◇—◇◇
Geoffrey ClappRSU———◇——◇
Mark LivingstonRSU———◇——◇
Mark LivingstonRSU———◇——◇
Mark LivingstonOPTION———◇—◇◇
Melissa CummingsRSU———◇——◇
Melissa CummingsOPTION———◇—◇◇
Melissa CummingsRSU———◇——◇
Peter AnevskiOPTION———◇—◇◇
Peter AnevskiRSU———◇——◇
Peter AnevskiRSU———◇——◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Peter AnevskiOption◇—◇10/17/2032
Option◇—◇12/31/2031
RSU◇◇——
RSU◇◇——
Option◇—◇3/2/2035
RSU◇◇——
Melissa CummingsOption◇—◇4/13/2035
RSU◇◇——
RSU◇◇——
Geoffrey ClappRSU◇◇——
Option◇—◇3/16/2035
RSU◇◇——
Mark LivingstonRSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇3/2/2035
Option◇—◇10/17/2032
Option◇—◇3/1/2033
RSU◇◇——
Option◇—◇3/3/2034
Allison SwartzRSU◇◇——
Option◇—◇3/2/2035
Option◇—◇11/27/2032
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇3/3/2034
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin Gordon
◇◇◇———◇
Jeff Park
Lead independent director
◇◇◇——◇◇
Roger Holstein
◇◇◇———◇
Lloyd Dean
◇◇◇———◇
Debra Morris
◇—◇———◇
Elizabeth Bierbower
◇—◇———◇
Norman Payson
◇◇◇———◇
Cheryl Scott
◇◇◇———◇
David Schlanger, Fred Cohen and Peter Anevski served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Lead independent director premium◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Alignment Healthcare, Inc. ALHC
  • Astrana Health, Inc. ASTH
  • Azenta, Inc. AZTA
  • Certara, Inc. CERT
  • CorVel Corporation CRVL
  • Evolent Health, Inc. EVH
  • Haemonetics Corporation HAE
  • HealthEquity, Inc. HQY
  • Masimo Corporation MASI
  • NeoGenomics, Inc. NEO
  • Omnicell, Inc. OMCL
  • Premier, Inc. PINC
  • Privia Health Group, Inc. PRVA
  • QuidelOrtho Corporation QDEL
  • R1 RCM Inc. RCM
  • RadNet, Inc. RDNT
  • Repligen Corporation RGEN
  • Sotera Health Company SHC
  • Teladoc Health, Inc. TDOC

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 21, 2026=◇◇◇
2024May 22, 2025=◇◇◇
2023May 23, 2024=◇◇◇
2022May 24, 2023=◇◇◇
2021May 25, 2022=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Progyny files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Progyny disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Progyny sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Progyny's disclosed peer group is defensible, who names Progyny back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
256 figures on this page: 251 cited to the filing that reported them, 5 calculated from figures it prints.
251 cited to the filing
5 calculated from the filing

Documents cited

  1. 0001551306-26-000109
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001551306-26-000055
    2025 Director Compensation Table · 2025 Summary Compensation Table · CEO Pay Ratio · DIRECTOR COMPENSATION · and 2 more sections
  3. 0001551306-25-000131
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001551306-25-000072
    2024 Summary Compensation Table
  5. 0001551306-24-000128
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001551306-24-000077
    2023 Summary Compensation Table
  7. 0001551306-23-000052
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001551306-23-000035
    Summary Compensation Table
  9. 0001558370-22-009468
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Progyny executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/PGNY (accessed 2026).
Short form: data: Velarion

The Progyny brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
9 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Progyny and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Peers Progyny discloses

The companies named in PGNY's own disclosed peer group.

Alignment Healthcare, Inc.Astrana Health, Inc.Azenta, Inc.Certara, Inc.CorVel CorporationEvolent Health, Inc.Haemonetics CorporationHealthEquity, Inc.Masimo CorporationNeoGenomics, Inc.Omnicell, Inc.Premier, Inc.Privia Health Group, Inc.QuidelOrtho CorporationR1 RCM Inc.RadNet, Inc.Repligen CorporationSotera Health CompanyTeladoc Health, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy